Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1 (original) (raw)
References
Amerongen AV, Sauerwein RW, Beckers PJA, Meloen RH, Meuwissen JHET (1989) Identification of a peptide sequence of the 25 kD surface protein of_Plasmodium falciparum_ recognized by transmission-blocking monoclonal antibodies: implications for synthetic vaccine development. Parasite Immunol 11: 425–428 Google Scholar
Amit AG, Mariuzza RA, Phillips SEV, Poljak RJ (1986) Three-dimensional structure of an antigen-antibody complex at 2.8 Å resolution. Science 233: 747–753 Google Scholar
Autiero M, Abrescia P, Dettin M, Di Bello C, Guardiola J (1991) Binding to CD 4 of synthetic peptides patterned on the principal neutralizing domain of the envelope protein. Virology 185: 820–828 Google Scholar
Back NKT, Thiriart C, Delers A, Ramautarsing C, Bruck C, Goudsmit J (1990) Association of antibodies blocking HIV-1 gp 160-sCD 4 attachment with virus neutralizing activity in human sera. J Med Virol 31: 200–208 Google Scholar
Bahraoui E, Clerget-Raslain B, Chapuis F, Olivier R, Paaravicini C, Yagello M, Montagnier L, Gluckman J-C (1988) A molecular mechanism of inhibition of HIV-1 binding to CD 4+ cells by monoclonal antibodies to gp 110. AIDS 2: 165–169 Google Scholar
Barany G, Merrifield RB (1980) Solid-phase peptide synthesis. In: Gross E, Meienhofer J (eds) The peptides: analysis, synthesis, biology, vol 2. Academic Press, New York London, pp 3–284 Google Scholar
Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Charnaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868–871 Google Scholar
Beatty JD, Beatty BG, Vlahos WG, Hill LR (1987) Method of analysis of non-competitive enzyme immunoassays for antibody quantification. J Immunol Methods 100: 161–172 Google Scholar
Celada F, Cambiaggi C, Maccari J, Burastero S, Gregory T, Patzer T, Porter J, McDanal C, Matthews T (1990) Antibody raised against soluble CD 4-gp 120 complex recognizes the CD 4 moiety and blocks membrane fusion without inhibiting CD 4-gp 120 binding. J Exp MEd 172: 1143–1150 Google Scholar
Clements GJ, Price-Jones MJ, Stephens PE, Sutton C, Schulz TF, Clapham PR, McKeating JR, McClure MO, Thomson S, Marsh M, et al (1991) The V 3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res Hum Retroviruses 7: 3–16 Google Scholar
Colman PM, Tulip WR, Varghese JN, Tulloch PA, Baker AT, Laver WG, Air GM, Webster RG (1989) 3-Dimensional structures of influenza-virus neuraminidase antibody complexes. Philos Trans R Soc Lond [Biol] 323: 511–518 Google Scholar
Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD 4(T 4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763–767 Google Scholar
Devash Y, Calvelli TA, Wood DG, Reagan KJ, Rubinstein A (1990) Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp 120 principal neutralization domain. Proc Natl Acad Sci USA 87: 3445–3449 Google Scholar
De Rossi A, Pasti M, Mammano F, Panozzo M, Dettin M, Di Bello C, Chieco-Bianchi L (1991) Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD 4-dependent mechanism. Virology 184: 187–196 Google Scholar
Doolittle RF (1985) Proteins. Scient Amer 253: 74 Google Scholar
Durda PJ, Bacheler L, Clapham P, Jenoski AM, Leece B, Matthews TJ, McKnight A, Pomerantz R, Rayner M, Weinhold KJ (1990) HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptide. AIDS Res Hum Retroviruses 9: 1115–1123 Google Scholar
Emini EA, Nara PL, Schleif WA, Lewis JA, Davide JP, Lee DR, Kessler J, Conley S, Matsushita S, Putney SD, Gerety RJ, Eichberg JW (1990) Antibody-mediated in vitro neutralization of human immundeficiency virus type 1 abolishes infectivity for chimpanzees. J Virol 64: 3674–3678 Google Scholar
Fieser TM, Tainer JA, Geysen HM, Houghten RA, Lerner RA (1987) Influence of protein flexibility and peptide conformation on reactivity of monoclonal anti-peptide antibodies with a protein α-helix. Proc Natl Acad Sci USA 84: 8568–8572 Google Scholar
Friguet B, Chaffotte AF, Djavadi-Ohaniance L, Goldberg ME (1985) Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 77: 305–319 Google Scholar
Geysen HM, Meloen RH, Barteling SJ (1984) Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci USA 81: 3998–4002 Google Scholar
Geysen HM, Barteling SJ, Meloen RH (1985) Small peptides induce antibodies with sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein. Proc Natl Acad Sci USA 82: 178–182 Google Scholar
Goudsmit J, Debouck C, Meloen RH, Smit L, Bakker M, Asher DM, Wolff AV, Gibbs CJ Jr, Gajdusek DC (1988) Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc Natl Acad Sci USA 85: 4478–4482 Google Scholar
Healey D, Dianda L, Moore J, McDougal JS, Moore MJ, Estess P, Buck D, Kwong PD, Beverley PCL, Sattentau QJ (1990) Novel anti-CD 4 monoclonal antibodies separate human immunodeficiency virus infection fusion of CD 4+ cells from virus binding. J Exp Med 172: 1233–1242 Google Scholar
Hwang SS, Boyle TJ, Lyerly HK, Cullen BR (1991) Identification of the envelope V 3 loop as the primary determinant of cell tropism in HIV-1. Science 253: 71–74 Google Scholar
Kinney-Thomas E, Weber JN, McClure J, Clapham PR, Singhal MC, Shriver MK, Weiss RA (1988) Neutralizing monoclonal antibodies to the AIDS virus. AIDS 2: 25–29 Google Scholar
Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hencend T, Gluckman J-C, Montagnier L (1984) T-lymphocyte T 4 molecule behaves as the receptor for human retrovirus LAV. Nature 312: 767–768 Google Scholar
Langedijk JPM, Back NKT, Durda PJ, Goudsmit J, Meloen RH (1991) Neutralizing activity of anti-peptide antibodies against the principal neutralization domain of HIV-1. J Gen Virol 72: 2519–2526 Google Scholar
LaRosa GJ, Davide JP, Weinhold K, Waterbury JA, Profy AT, Lewis JA, Langlois AJ, Dreesman GR, Boswell RN, Shadduck P, Holley LH, Karplus M, Bolognesi DP, Matthews TJ, Emini EA, Putney SD (1990) Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249: 932–935 Google Scholar
Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, Gregory TJ (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp 120) expressed in Chinese hamster ovary cells. J Biol Chem 265: 10373–10382 Google Scholar
Linsley PS, Ledbetter JA, Kinney-Thomas E, Hu S-L (1988) Effects of anti-gp 120 monoclonal antibodies on CD 4 receptor binding by the env protein of human immunodeficiency virus type 1. J Virol 62: 3695–3702 Google Scholar
Metlas R, Veljkovic V, Paladini RD, Pongor S (1991) Protein and DNA-sequence homologies between the V 3-loop of human immundeficiency virus type 1 envelope protein-gp 120 and immunoglobulin variable regions. Biochem Biophys Res Commun 179: 1056–1062 Google Scholar
Nara PL (1988) Neutralization of HIV-1, a binding/postbinding event mediated through the gp 120 immunodominant epitope. In: Girard M, Valetee L (eds) Retrovirus of human AIDS and related animal diseases. Pasteur Vaccines, Paris, pp 138–150 Google Scholar
Novotny J, Bruccoleri RE, Saul FA (1989) On the attribution of binding energy in antigen-antibody complexes McPC 603, D 1.3, and HyHEL-5. Biochemistry 28: 4735–4749 Google Scholar
Padlan EA, Silverston EW, Sheriff S, Cohen BH, Smith-Gill SJ, Davies DR (1989) Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fablysozyme comlex. Proc Natl Acad Sci USA 86: 5938–5942 Google Scholar
Palker RR, Clark ME, Langlois SJ, Matthews TJ, Weinhold KJ, Randall RR, Bolognesi DP, Haynes BF (1988) Tpye-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc Natl Acad Sci USA 85: 1932–1936 Google Scholar
Posthumus WPA, Lenstra JA, Schaaper WMM, Nieuwstad APV, Enjuanes L, Meloen RH (1990) Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus. J Virol 64: 3304–3309 Google Scholar
Putney SD, Matthews TJ, Robey WG, Lynn DL, Robert-Guroff M, Mueller WT, Langlois AJ, Ghrayeb J, Petteway SR, Weinhold KJ, Fischinger PJ, Wong-Staal F, Gallo RC, Bolgnesi DP (1986) HTLV-IIIB/LAV neutralizing antibodies to an E. coliproduced fragment of the virus envelope. Science 234: 1392–1395 Google Scholar
Ratner L, Haseltine W, Patarca R, Livak KJ, Starcich B, Josephs SF, Doran ER, Rafalski JA, Whitehorn EA, Baumeister K, Ivanoff L, Petteway S, Pearson M, Lautenberger Papas T, Ghrayeb J, Chang T, Gallo RC, Wong-Staal F (1985) Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313: 277–284 Google Scholar
Robey WG, Arthur LO, Matthews TJ, Langlois A, Copeland TD, Lerche NW, Oroszlan S, Bolognesi DP, Gilden RV, Fischinger PJ (1986) Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc Natl Acad Sci USA 83: 7023 Google Scholar
Rusche JR, Lynn DL, Robert-Guroff M, Langlois AJ, Lyerly HK, Carson H, Krohn K, Ranlu A, Gallo RC, Bolognesi DP, Putney SD, Matthews TJ (1987) Humoral immune response to the entire human immunodeficiency virus envelope glycoproteins made in insect cells. Proc Natl Acad Sci USA 84: 6924–6928 Google Scholar
Rusche JR, Javaherian K, McDanal C, Petro J, Lynn DL, Grimaila R, Langlois A, Gallo RC, Arhur LO, Fishinger PJ, Bolognesi DP, Putney SD, Matthews TJ (1988) Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp 120. Proc Natl Acad Sci USA 85: 3198–3202 Google Scholar
Sattentau QJ, Weiss RA (1988) The CD 4 antigen: physiological ligand and HIV receptor (review). Cell 52: 631–633 Google Scholar
Schaaper WMM, Lankhof H, Puijk WC, Meloen RH (1989) Manipulation of antipeptide immune response by varying the coupling of the peptide with the carrier protein. Mol Immunol 26: 81–85 Google Scholar
Shapira M, Jibson M, Muller G, Amon G (1984) Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of haemagglutin. Proc Natl Acad Sci USA 81: 2461–2465 Google Scholar
Sheriff S, Silverton EW, Padlan EA, Cohen GH, Smith-Gill SJ, Finzel BC, Davies DR (1987) Three-dimensional structure of an antibody-antigen complex. Proc Natl Acad Sci USA 84: 8075–8079 Google Scholar
Skinner MA, Langlois AJ, McDanal CB, McDougal JS, Bolognesi DP, Matthews TJ (1988) Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp 120 binding to CD 4. J Virol 62: 4195–4200 Google Scholar
Skinner MA, Ting R, Langlois AJ, Weinhold KJ, Lyerly HK, Javaherian K, Matthews TJ (1988) Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. AIDS Res Hum Retrovirus 4: 187–197 Google Scholar
Stanfield RL, Fieser TM, Lerner RA, Wilson IA (1990) Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 Å. Science 248: 712–719 Google Scholar
Stephens PE, Clements G, Yarranton GT, Moore J (1990) A chink in HIV armour? Nature 343: 219 Google Scholar
Stevens FJ (1987) Modification of an ELISA-based procedure for affinity determination: correction necessary for use with bivalent antibody. Mol Immunol 10: 1055–1060 Google Scholar
Stewart MW, Lew AM (1985) The importance of antibody affinity in the performance of immunoassays for antibody. J Immunol Methods 78: 173–190 Google Scholar
Suter M (1982) A modified ELISA technique for hapten antibodies. J Immunol Methods 53: 103–108 Google Scholar
Takeuchi Y, Akutsu M, Murayama K, Shimizu N, Hoshino H (1991) Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene. J Virol 65: 1710–1718 Google Scholar
Thiriart C, Francotte M, Cohen J, Collignon C, Delers A, Kummert S, Molitor C, Gilles D, Roelants P, Van Wijnendaele F, De Wilde M, Bruck C (1989) Several antigenic determinants exposed on the gp 120 moiety of HIV-1 gp 160 are hidden on the mature gp 120. J Immunol 43: 1832–1836 Google Scholar
Truneh A, Buck D, Cassatt DR, Juszczak R, Kasis S, Ryu S, Healey D, Sweet R, Sattentau QJ (1991) A region in domain 1 of CD 4 distinct from the primary gp 120 binding site is involved in HIV infection and virus-mediated fusion. J Biol Chem 266: 5942–5948 Google Scholar
Westervelt P, Gendelman HE, Ratner L (1991) Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc Natl Acad Sci USA 88: 3097–3101 Google Scholar
Williams WV, Keiber-Emmons T, VonFeldt J, Greene MI, Wiener DB (1991) Design of bioactive peptides based on antibody hypervariable region structures. J Biol Chem 266: 5182–5190 Google Scholar